Everything below concerns incretin. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Free base form |
| Molecular mass | Approximately 4813 Da | Calculated from the sequence |
| Amino acid residues | 39 | GIP-derived backbone |
| Receptor targets | GIP and GLP-1 | Dual agonist |
| Circulating half-life | About 5 days | Supports weekly administration |
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Channelopathies can be categorized based on the organ system they affect. In the cardiovascular system, the electrical impulse required for each heart beat is provided by the electrochemical gradient of each heart cell. Because the beating of the heart depends on the proper movement of ions across the surface membrane, cardiac ion channelopathies form a major group of heart diseases. Cardiac ion channelopathies may explain some of the cases of sudden death syndrome and sudden arrhythmic death syndrome. Long QT syndrome is the most common form of cardiac channelopathy.
== Neutrophil antigens == There are five (HNA 1–5) sets of neutrophil antigens recognized. The three HNA-1 antigens (a-c) are located on the low affinity Fc-γ receptor IIIb (FCGR3B :CD16b) The single known HNA-2a antigen is located on CD177. The HNA-3 antigen system has two antigens (3a and 3b) which are located on the seventh exon of the CLT2 gene (SLC44A2). The HNA-4 and HNA-5 antigen systems each have two known antigens (a and b) and are located in the β2 integrin. HNA-4 is located on the αM chain (CD11b) and HNA-5 is located on the αL integrin unit (CD11a).
Noriega's rule became increasingly repressive, even as the U.S. government of Ronald Reagan began relying on him in its covert efforts to undermine Nicaragua's Sandinista government. The U.S. accepted Barletta's election, and signalled a willingness to cooperate with him, despite being aware of the flaws in the election process.
At the time, Senator Hatch's son was working for a firm hired to lobby Congress and the FDA on behalf of ephedra manufacturers. In addition to the activities of the Ephedra Education Council, Metabolife spent more than $4 million between 1998 and 2000 lobbying against state regulation of ephedra in Texas. Business Week reported that efforts to regulate ephedra and other potentially harmful supplements had been "beaten down by deep-pocketed industry lobbying." In 2000, the FDA withdrew the proposed labeling changes and restrictions.
=== N-Acetylglutamic acid === The synthesis of carbamoyl phosphate and the urea cycle are dependent on the presence of N-acetylglutamic acid (NAcGlu), which allosterically activates CPS1. NAcGlu is an obligate activator of carbamoyl phosphate synthetase. Synthesis of NAcGlu by N-acetylglutamate synthase (NAGS) is stimulated by both Arg, allosteric stimulator of NAGS, and Glu, a product in the transamination reactions and one of NAGS's substrates, both of which are elevated when free amino acids are elevated. So Glu not only is a substrate for NAGS but also serves as an activator for the urea cycle.
Sources: en.wikipedia.org
An attempted motorcycle bomb attack on a Police APC was foiled in Lakki Marwat District. On 12 June, an alleged TTP commander was killed in a police operation in Bannu District, two bodies of civilians killed by militants were also recovered and an attempt to destroy a bridge was foiled. Pakistani forces claimed that they had concluded Operation Iron Fist-3, which was carried out from 1-12 June 2026, killing 62 TTP militants including four commanders and capturing eight, destroying 14 militant infrastructure sites, with 48 insurgents being killed in the second phase of operations, according to ISPR. Two civilians were killed and several wounded in a suicide blast near a mosque in Lakki Marwat. On 13 June, a religious scholar was assassinated by TTP and a bridge and a mosque were damaged in an attack by TTP insurgents in Bannu District. CTD captured the brother of an Afghan TTP militant, who himself was allegedly involved in supplying drones, electronic equipment and phones to TTP insurgents. On 14 June, militants attacked a police checkpoint in Kurram District killing a civilian and wounding three police officers, after which militant hideouts were struck by Pakistani artillery fire. 12 insurgents were killed in an infiltration attempt across the border from Afghanistan in Chaman District. Four peace committee members were killed in a TTP attack in Lakki Marwat District and ten suspected insurgents were arrested from Karak District. A TTP drone strike in Kurram District killed four civilians and wounded four more.
A vibrator (such as a clitoral vibrator), dildo or other sex toy may be used. Other women stimulate the clitoris by use of a pillow or other inanimate object, by a jet of water from the faucet of a bathtub or shower, or by closing their legs and rocking.
== History == Some of the first examples of PPy were reported in 1919 by Angeli and Pieroni, who reported the formation of pyrrole blacks from pyrrole magnesium bromide. Since then pyrrole oxidation reaction has been studied and reported in scientific literature. Work on conductive polymers including polypyrrole, polythiophene, polyaniline, and polyacetylene was awarded the Nobel Prize in Chemistry in 2000 to Alan J. Heeger, Alan G. MacDiarmid and Hideki Shirakawa.
==== Ecuador ==== Caldo de tronquito is an Ecuadoran cuisine bull penis soup. The soup features grains like hominy and corn, beans like chickpeas and fava beans, and offal like tripe and testicles; the ingredients are comparable to a fanesca with meat. Regional variations include Manabí, where peanuts and milk are added, and La Costa, which favors corn, cassava and carrots. The soup is eaten as a hangover cure, to treat anemia, assist recovery from sickness or post-partum, and as an aphrodisiac. Caldo de tronquito was created in 16th century Quito after the Spanish colonization of Ecuador introduced cattle to the continent.
Sources: en.wikipedia.org
=== Surface modification improving cell adhesion === Surface modification can also affect properties that promote cell adhesion. One particular research in 2005 studied the mammalian cell adhesion on the modified surfaces of porous silicon. The research used rat PC12 cells and Human Lens Epithelial (HLE) cells cultured for four hours on the surface modified porous silicon. Cells were then stained with vital dye FDA and observed under fluorescence microscopy. The research concluded that "amino silanisation and coating the pSi surface with collagen enhanced cell attachment and spreading".
=== Contraindications === Ketosis induced by a ketogenic diet should not be pursued by people with pancreatitis because of the high dietary fat content. Ketosis is also contraindicated in pyruvate carboxylase deficiency, porphyria, and other rare genetic disorders of fat metabolism.
Copurification in a chemical or biochemical context is the physical separation by chromatography or other purification technique of two or more substances of interest from other contaminating substances. For substances to co-purify usually implies that these substances attract each other to form a non-covalent complex such as in a protein complex. However, when fractionating mixtures, especially mixtures containing large numbers of components (for example a cell lysate), it is possible by chance that some components may copurify even though they don't form complexes. In this context the term copurification is sometimes used to denote when two biochemical activities or some other property are isolated together after purification but it is not certain if the sample has been purified to homogeneity (i.e., contains only one molecular species or one molecular complex). Hence these activities or properties are likely but not guaranteed to reside on the same molecule or in the same molecular complex.
== Personal life == Kennedy and his wife, Becky, are founding members of their local Methodist church in Madisonville. Despite sharing the first and last name of the 35th president of the United States, he is not related to the Kennedy family of Massachusetts. Members of Kennedy's family were slaveowners before the Civil War, and have been political and economic elites in Louisiana since the 19th century. Kennedy's great-great-great-grandfather enslaved 120 people in Catahoula and Concordia Parishes. After the Civil War, Kennedy's great-grandfather Leonidas Calhoun Kennedy inherited hundreds of acres of land in Catahoula when his mother died and turned to sharecropping to work the land.
The potential for the EPRDF to assume total power in the Transitional Government was suspected by many from the beginning. At the 1991 National Conference on Peace and Reconciliation, one foreign onlooker commented that "[although the 1991 conference may not have resulted in a one party government[,] its convention reflects to a large degree a one party dynamic." The terms of the resulting charter were likewise mainly drawn from the key ideals of the EPRDF (particularly those of the TPLF). In addition, the president of the TGE was Meles Zenawi, chairman of the TPLF; his colleague, fellow EPRDF leader Tamrat Layne, became the prime minister. Thirty-two of the eighty-seven seats in the Council of Representatives were filled by EPRDF members as well. The TGE also took steps to cleanse the government of any traces of the previous regime, such as removing and replacing the occupants of almost all senior government posts, reorganizing all state agencies and institutions, and disbanding the Derg's large military force.
Sources: en.wikipedia.org
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.
A fatty diacid side chain promotes binding to albumin, which delays clearance from circulation. The half-life of roughly five days makes a weekly schedule practical.
No. It is a synthetic peptide whose backbone is based on the natural incretin hormone GIP. Non-natural residues and the lipid side chain were engineered to improve stability and duration of action.
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.